Sheila Raghavan

859 total citations
26 papers, 625 citations indexed

About

Sheila Raghavan is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Obstetrics and Gynecology. According to data from OpenAlex, Sheila Raghavan has authored 26 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Public Health, Environmental and Occupational Health, 20 papers in Pediatrics, Perinatology and Child Health and 16 papers in Obstetrics and Gynecology. Recurrent topics in Sheila Raghavan's work include Reproductive Health and Contraception (20 papers), Maternal and fetal healthcare (17 papers) and Maternal and Perinatal Health Interventions (15 papers). Sheila Raghavan is often cited by papers focused on Reproductive Health and Contraception (20 papers), Maternal and fetal healthcare (17 papers) and Maternal and Perinatal Health Interventions (15 papers). Sheila Raghavan collaborates with scholars based in United States, Bangladesh and Türkiye. Sheila Raghavan's co-authors include Beverly Winikoff, Jennifer Blum, Rasha Dabash, Nguyen Thi Nhu Ngoc, Beverly Winikoff, Ayisha Diop, Jill Durocher, Blami Dao, Tara Shochet and H Chelli and has published in prestigious journals such as The Lancet, Obstetrics and Gynecology and BJOG An International Journal of Obstetrics & Gynaecology.

In The Last Decade

Sheila Raghavan

25 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sheila Raghavan United States	14	504	447	431	75	22	26	625
Tara Shochet United States	9	286 0.6×	273 0.6×	227 0.5×	18 0.2×	19 0.9×	20	409
Ayisha Diop United States	12	320 0.6×	257 0.6×	260 0.6×	46 0.6×	18 0.8×	23	382
RA Greene Ireland	8	250 0.5×	110 0.2×	197 0.5×	65 0.9×	15 0.7×	19	294
Robyn M Kennare Australia	6	282 0.6×	118 0.3×	248 0.6×	12 0.2×	52 2.4×	7	352
S Arulkumaran United Kingdom	10	211 0.4×	125 0.3×	207 0.5×	13 0.2×	36 1.6×	22	324
Rodrigo S. Camargo Brazil	12	243 0.5×	113 0.3×	194 0.5×	13 0.2×	71 3.2×	13	335
B.W. Mol Netherlands	11	254 0.5×	148 0.3×	191 0.4×	8 0.1×	29 1.3×	24	430
Martina Murphy Ireland	9	485 1.0×	165 0.4×	540 1.3×	18 0.2×	35 1.6×	13	594
Stine Bernitz Norway	11	254 0.5×	111 0.2×	304 0.7×	23 0.3×	30 1.4×	25	340
Anna Heino Finland	7	160 0.3×	131 0.3×	129 0.3×	6 0.1×	36 1.6×	27	308

Countries citing papers authored by Sheila Raghavan

Since Specialization

Citations

This map shows the geographic impact of Sheila Raghavan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheila Raghavan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheila Raghavan more than expected).

Fields of papers citing papers by Sheila Raghavan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheila Raghavan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheila Raghavan. The network helps show where Sheila Raghavan may publish in the future.

Co-authorship network of co-authors of Sheila Raghavan

This figure shows the co-authorship network connecting the top 25 collaborators of Sheila Raghavan. A scholar is included among the top collaborators of Sheila Raghavan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheila Raghavan. Sheila Raghavan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dabash, Rasha, H Chelli, Selma Hajri, et al.. (2015). A double‐blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14–21 weeks of pregnancy. International Journal of Gynecology & Obstetrics. 130(1). 40–44. 37 indexed citations

Raghavan, Sheila, et al.. (2013). Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine: Results of two clinical trials. The European Journal of Contraception & Reproductive Health Care. 18(2). 112–119. 4 indexed citations

Raghavan, Sheila, et al.. (2013). Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: Evidence from Uzbekistan. The European Journal of Contraception & Reproductive Health Care. 18(2). 104–111. 9 indexed citations

Alam, Anadil, Hillary Bracken, Heidi Bart Johnston, et al.. (2013). Acceptability and Feasibility of Mifepristone-Misoprostol for Menstrual Regulation in Bangladesh. International Perspectives on Sexual and Reproductive Health. 39(2). 79–87. 13 indexed citations

Raghavan, Sheila, et al.. (2012). Misoprostol for prevention and treatment of postpartum hemorrhage: What do we know? What is next?. International Journal of Gynecology & Obstetrics. 119(S1). S35–8. 14 indexed citations

Raghavan, Sheila, Nguyen Thi Nhu Ngoc, Tara Shochet, & Beverly Winikoff. (2012). Clinic‐level introduction of medical abortion in Vietnam. International Journal of Gynecology & Obstetrics. 119(1). 39–43. 6 indexed citations

Dabash, Rasha, Jennifer Blum, Sheila Raghavan, Holly Anger, & Beverly Winikoff. (2012). Misoprostol for the management of postpartum bleeding: A new approach. International Journal of Gynecology & Obstetrics. 119(3). 210–212. 5 indexed citations

Blum, Jennifer, Sheila Raghavan, Rasha Dabash, et al.. (2012). Comparison of misoprostol‐only and combined mifepristone–misoprostol regimens for home‐based early medical abortion in Tunisia and Vietnam. International Journal of Gynecology & Obstetrics. 118(2). 166–171. 31 indexed citations

Dabash, Rasha, Jennifer Blum, Sheila Raghavan, et al.. (2012). O155 OUTCOMES OF A DOUBLE‐BLIND RANDOMIZED TRIAL COMPARING MISOPROSTOL‐ONLY TO MIFEPRISTONE+MISOPROSTOL FOR HOME‐BASED EARLY MEDICAL ABORTION. International Journal of Gynecology & Obstetrics. 119(S3). 3 indexed citations

10.

Ngoc, Nguyen Thi Nhu, Tara Shochet, Sheila Raghavan, et al.. (2011). Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-Trimester Abortion. Obstetrics and Gynecology. 118(3). 601–608. 67 indexed citations

11.

Dabash, Rasha, Selma Hajri, Shuchita Mundle, et al.. (2011). The extended gestational age medical abortion study: the effectiveness of medical abortion with 200 mg mifepristone and 400 mcg sublingual misoprostol at 57–63 days vs. 64–70 days gestation. Contraception. 84(3). 303–303.

12.

Blum, Jennifer, Beverly Winikoff, Sheila Raghavan, et al.. (2011). Treatment of Postpartum Hemorrhage With Sublingual Misoprostol Versus Oxytocin in Women Receiving Prophylactic Oxytocin. Obstetric Anesthesia Digest. 31(1). 34–34. 11 indexed citations

13.

Ngoc, Nguyen Thi Nhu, Jennifer Blum, Sheila Raghavan, et al.. (2010). Comparing two early medical abortion regimens: mifepristone+misoprostol vs. misoprostol alone. Contraception. 83(5). 410–417. 37 indexed citations

14.

Winikoff, Beverly, Rasha Dabash, Jill Durocher, et al.. (2010). Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial. The Lancet. 375(9710). 210–216. 96 indexed citations

15.

Blum, Jennifer, Beverly Winikoff, Sheila Raghavan, et al.. (2010). Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial. The Lancet. 375(9710). 217–223. 93 indexed citations

16.

Diop, Ayisha, et al.. (2009). Two routes of administration for misoprostol in the treatment of incomplete abortion: a randomized clinical trial. Contraception. 79(6). 456–462. 31 indexed citations

17.

Ngoc, Nguyen Thi Nhu, et al.. (2009). O673 Medical abortion with misoprostol only versus mifepristone plus misoprostol: Results from a randomized controlled trial. International Journal of Gynecology & Obstetrics. 107(S2). 1 indexed citations

18.

Blum, Jennifer, Beverly Winikoff, Sheila Raghavan, et al.. (2009). I86 Treatment of postpartum hemorrhage with sublingual misoprostol versus oxytocin: Results from a randomized non‐inferiority trial among women receiving prophylactic oxytocin. International Journal of Gynecology & Obstetrics. 107(S2). 3 indexed citations

19.

Raghavan, Sheila, et al.. (2008). Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol. Contraception. 79(2). 84–90. 25 indexed citations

20.

Dao, Blami, Jennifer Blum, Blandine Thiéba, et al.. (2007). Is misoprostol a safe, effective and acceptable alternative to manual vacuum aspiration for postabortion care? Results from a randomised trial in Burkina Faso, West Africa. BJOG An International Journal of Obstetrics & Gynaecology. 114(11). 1368–1375. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact